Navigation Links
Investigational anti-restenosis drug pimecrolimus disappoints
Date:3/31/2008

CHICAGO, Ill. (March 31, 2008) A new medication that researchers had hoped would reduce the risk of arterial renarrowing after stenting has turned in a disappointing performance in a multicenter clinical trial, but the multi-reservoir stent that was used to deliver the drug is still considered promising.

Pimecrolimus, an anti-inflammatory medication, was expected to reduce arterial inflammation and, therefore, the overgrowth of scar tissue, or neointimal hyperplasia, that causes in-stent restenosis. Instead, patients treated with pimecrolimus-eluting stents fared far worse than patients treated with stents that delivered a combination of pimecrolimus and paclitaxel, or paclitaxel alone, according to the Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries (GENESIS). Paclitaxel is also an anti-restenosis medication, but it works by inhibiting cell division, rather than by reducing arterial inflammation.

The GENESIS study was terminated early by its sponsors. The data gathered to that point are being reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC).

Despite pre-clinical data suggesting marked efficacy of pimecrolimus in suppressing neointimal hyperplasia, the extent of tissue growth and resulting rates of target vessel revascularization at six months were high in patients treated with this drug, said Stefan Verheye, MD, PhD, co-director of the catheterization laboratories at Antwerp Cardiovascular Center, ZNA Middelheim Hospital, Antwerp, Belgium.

The GENESIS study was als
'/>"/>

Contact: Kathy Boyd David
pr@scai.org
717-422-1181
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Investigational drug tested for preventing muscle fiber death in muscular dystrophy
2. Enrollment completed in 2 pivotal phase III studies of the investigational cancer drug vandetanib
3. New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets
4. UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
5. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
6. MetaCure(TM) Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight
7. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
8. Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
9. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
10. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
11. Accentia announces investigational new drug application for Revimmune for refractory MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... MA (PRWEB) May 05, 2015 Lauren ... goods retailer City Sports , was named one ... and active lifestyle industry by the SportsOneSource ... , Ms. Blanda, 33, is one of 40 executives ... Sporting Goods Business magazine) recognized for exceptional achievement in ...
(Date:5/4/2015)... Parlin, New Jersey (PRWEB) May 04, 2015 ... contest to give a chance to more youths to participate ... to encourage youths in her area to do good deeds ... behavior, Dr.Blagoev intends to empower their minds and teach them ... The contest is accessible to any youth 18 years of ...
(Date:5/4/2015)... NY (PRWEB) May 05, 2015 ... honors Irene Taylor , Volunteer Executive ... as a 2015-2016 inductee into its VIP Woman ... this prestigious distinction for leadership in business. NAPW ... professional women, boasting more than 700,000 members and ...
(Date:5/4/2015)... (PRWEB) May 05, 2015 The ... Patti Hommes as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor,” says NAPW President Star Jones. ...
(Date:5/4/2015)... 05, 2015 The National Association ... Betancourt as a 2015-2016 inductee into the NAPW ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor," said NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 2Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 3Health News:10 More Days To Enter Good Deed Contest 2Health News:National Association of Professional Women Inducts Irene Taylor into its 2015-2016 VIP Woman of the Year Circle 2Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2
... N.C., Nov. 24 In January, victorious,politicians will go ... and health care, but patients don,t have to wait ... care. Instead, they should give,feedback directly to their doctors, ... "We don,t know whether ...
... LOS ANGELES, Nov. 24 To everyone around her, ... acting career, a successful clothing,line that was attracting international ... that for years, Melissa suffered from severe,breathing problems, extreme ... cause. , After ...
... easier, Fresho.com becomes a job search engine with the functionality of a ... ... Due to the current economic woes, employment sites are experiencing an increase ... increasing demand for new job openings, Fresho has changed its business concept ...
... A new study found that adolescents were at the greatest ... early age and the parents, smoking quickly reached high levels ... the November issue of Health Psychology , draws from ... research that suggests smoking behavior is influenced by both genetics ...
... ultrasound waves for deep vein thrombosis (DVT) may help dissolve ... according to researchers at Emory University. The study will be ... New York City. , "These clots are a main cause ... you can eliminate them the better," says Karthikeshwar Kasirajan, MD, ...
... its kind, researchers at the Yerkes National Primate ... have developed a multidisciplinary approach involving immunology, genomics ... vaccine without exposing individuals to infection. This approach ... vaccines--that of only being able to determine immunity ...
Cached Medicine News:Health News:Politicians May Not Listen ... But Doctors Do, Says DrScore 2Health News:Do You Have Genetic COPD? 2Health News:Fresho.com Adapts As The Online Recruiting Market Heats Up 2Health News:Smoking, teens and their parents: New research 2Health News:Ultrasound waves aid in rapid treatment of DVT 2Health News:Researchers discover strategy for predicting the immunity of vaccines 2
(Date:5/4/2015)... , May 4, 2015  Makindus, Inc. a ... that the European Medicines Agency (EMA) has granted orphan ... treatment of Stargardt,s Disease. "We are extremely ... to treat Stargardt,s disease in place for ... program in the United States ...
(Date:5/4/2015)... -- By looking at the brain, scientists believe it ... different conditions that can have very similar symptoms. ... a Denver -based psychiatrist specializing ... can help the medical community better identify the ... Stress Disorder (PTSD) and Traumatic Brain Injury (TBI). ...
(Date:5/4/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has entered ... to develop and commercialize ISIS-FXI Rx for the ... Isis is eligible to receive up to $155 million ... payment and a $55 million payment upon advancement of ... with compromised kidney function. Isis is also eligible to ...
Breaking Medicine Technology:European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... Equity Fund (EEF), a healthcare-focused private equity firm, and ... Inc. (MedTest), a medical diagnostic company based in Cortlandt ... diagnostics business from Polymedco, Inc.  The transaction was led ... not disclosed. "EEF is committed to building ...
... / PRNewswire / -- Silicon Valley ... life science companies worldwide, released a study ... private, venture capital-backed biotech and medical device companies. ... acquisition transactions of US venture-capital backed companies (60 biotech ...
Cached Medicine Technology:Enhanced Equity Fund and James White Invest in MedTest DX, Inc. 2Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 2Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 3
Total T3 EIA Thyroid Function 025-BC-1005...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Free Estriol (E3) RIA Reproductive Hormones 024-IDC-2000...
... Hydroxyprogesterone (17aOHP) is produced by both ... 17aOHP has relatively little progestational activity, ... because it is the,immediate precursor to ... by 21-hydroxylation of 17aOHP,measurement of 17aOHP ...
Medicine Products: